Fabiana Ciciriello

Rome, 00165, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Prenatal Elexacaftor/Tezacaftor/Ivacaftor for Fetal Meconium Ileus: First Italian Case and Narrative Overview of the Emerging Evidence.

Prenatal Elexacaftor/Tezacaftor/Ivacaftor for Fetal Meconium Ileus: First Italian Case and Narrative Overview of the Emerging Evidence.

Journal: Journal of clinical medicine

Published: February 19, 2026

Evaluation of ATP12A and NFKBIZ as potential markers of inflammatory status in cystic fibrosis airway epithelial cells.

Evaluation of ATP12A and NFKBIZ as potential markers of inflammatory status in cystic fibrosis airway epithelial cells.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: September 30, 2025

Phosphatidylserine liposomes for Mycobacterium abscessus infections management in people with cystic fibrosis non-eligible for CFTR modulators.

Phosphatidylserine liposomes for Mycobacterium abscessus infections management in people with cystic fibrosis non-eligible for CFTR modulators.

Journal: Frontiers in immunology

Published: August 07, 2025

The CFTR gene variants in paediatric nasal polyposis: a study in the Italian population.

The CFTR gene variants in paediatric nasal polyposis: a study in the Italian population.

Journal: Rhinology

Published: June 30, 2025

Height Velocity in Pediatric Cystic Fibrosis Under Triple CFTR Modulator Therapy: A Real-Life Monocentric Experience.

Height Velocity in Pediatric Cystic Fibrosis Under Triple CFTR Modulator Therapy: A Real-Life Monocentric Experience.

Journal: Journal of clinical medicine

Published: June 16, 2025

Rescue of the CFTR chloride channel with nonsense mutations is markedly improved under inflammatory conditions.

Rescue of the CFTR chloride channel with nonsense mutations is markedly improved under inflammatory conditions.

Journal: The European respiratory journal

Published: June 09, 2025

Development and Validation of a New LC-MS/MS Method for Simultaneous Quantification of Ivacaftor, Tezacaftor and Elexacaftor Plasma Levels in Pediatric Cystic Fibrosis Patients.

Development and Validation of a New LC-MS/MS Method for Simultaneous Quantification of Ivacaftor, Tezacaftor and Elexacaftor Plasma Levels in Pediatric Cystic Fibrosis Patients.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 28, 2025

Mutations with residual CFTR function are associated with better glucose tolerance and insulin secretion in people with Cystic fibrosis.

Mutations with residual CFTR function are associated with better glucose tolerance and insulin secretion in people with Cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: March 03, 2025

COVID-19 in people with Cystic Fibrosis beyond the pre-omicron era: a prospective study with a specific focus on long COVID.

COVID-19 in people with Cystic Fibrosis beyond the pre-omicron era: a prospective study with a specific focus on long COVID.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: January 31, 2025

Phosphatidylinositol 5-Phosphate-Loaded Apoptotic Body-Like Liposomes for Mycobacterium abscessus Infection Management in Patients With Cystic Fibrosis.

Phosphatidylinositol 5-Phosphate-Loaded Apoptotic Body-Like Liposomes for Mycobacterium abscessus Infection Management in Patients With Cystic Fibrosis.

Journal: The Journal of infectious diseases

Published: December 17, 2024

IL-17 family members exert an autocrine pro-inflammatory loop in CF respiratory epithelial cells ex vivo.

IL-17 family members exert an autocrine pro-inflammatory loop in CF respiratory epithelial cells ex vivo.

Journal: Cellular immunology

Published: October 31, 2024

Deleterious effect of Pseudomonas aeruginosa on F508del-CFTR rescued by elexacaftor/tezacaftor/ivacaftor is clinical strain-dependent in patient-derived nasal cells.

Deleterious effect of Pseudomonas aeruginosa on F508del-CFTR rescued by elexacaftor/tezacaftor/ivacaftor is clinical strain-dependent in patient-derived nasal cells.

Journal: ERJ open research

Published: September 23, 2024

Showing 1-12 of 31

Last Updated: 09/26/2026